Work

MA13.02 Phase II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Recurrent Non-Small Cell Lung Cancer

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.08.176

Authors: S. Puri, T. Tanvetyanon, B. Creelan, M. Shafique, A. Saltos, A. Chiappori, E. Haura, R. Thapa, D. Chen, S. Antonia, J. Gray

Institutions: Huntsman Cancer Institute, Moffitt Cancer Center, Duke Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3205811711

Cites:

Cited by: 4

Related to: 10